Greenwich Lifesciences Inc 公布了其2026年第二季度的财务预期。公司预计该季度的现金消耗率约为200万美元。与此同时,截至2026年6月30日,公司的现金及现金等价物余额为890万美元。这些数据反映了公司在特定时期的资金使用状况与财务流动性。
Greenwich Lifesciences Inc 公布了其2026年第二季度的财务预期。公司预计该季度的现金消耗率约为200万美元。与此同时,截至2026年6月30日,公司的现金及现金等价物余额为890万美元。这些数据反映了公司在特定时期的资金使用状况与财务流动性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.